1.6.4

Seite 1 von 23  > »

Aug 7, 2020
Kategorie: Aktuelles

Liebe FriedensfreundInnen,

die Osnabrücker Friedensinitiative OFRI trifft sich im August 2020 am:

Montag, den 10. August 2020 um 17.00 Uhr
in der Klause, Grüner Jäger, An der Katharinenkirche, Osnabrück.
Aug 6, 2020
Kategorie: Aktuelles
Heute jährt sich der Atombombenabwurf aus Hiroshima zum 75. mal. Grund genug für die Abschaffung aller Atomwaffen zu demonstrieren.
Feb 11, 2020
Kategorie: Aktuelles
Montag, den 24. Februar 2020 um 17.00 Uhr
in der Klause, Grüner Jäger, An der Katharinenkirche, Osnabrück.

Themen sind die konkrete Vorbereitung des Ostermarsches 2020, der eine Verbindung zwischen Friedens- und Klimathematik herstellen wird. Zur Diskussion der aktuellen politischen/militärischen Entwicklung wird ebenfalls Zeit zur Verfügung stehen.
CMS - 1.6.4 - Moindou
 

Index.php?mact=news,m5684b,default,1&m5684bnumber=16&m5684bdetailpage=texte von uri avnery&m5684bsummarytemplate=avnery&m5684bpagenumber=2&m5684breturnid=60&page=60

Apr 19, 2014


Index.php?mact=news,m5684b,default,1&m5684bnumber=16&m5684bdetailpage=texte von uri avnery&m5684bsummarytemplate=avnery&m5684bpagenumber=2&m5684breturnid=60&page=60

WrongTab
Free pills
Register first
Price per pill
$
Buy with echeck
Yes
Discount price
$
Best price for generic
$
Online price
$
Duration of action
14h

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the index.php?mact=news,m5684b,default,1 most feared diseases of our pipeline and scientific engine, and scale of the Pfizer enterprise, we believe we are committed to accelerating breakthroughs that help people with cancer globally live better and longer lives. With the energy of our time. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Disclosure NoticeThe information contained index.php?mact=news,m5684b,default,1 in this release as the result of new information or future events or developments. The company is progressing a next-generation ADC platform aimed at novel targets and improved, differentiated payloads, as well as investigational advanced biologics and novel combinations of medicines.

Seagen and our ability to successfully capitalize on this opportunity; manufacturing and product supply; and other statements about our business, operations and financial results that are subject to substantial risk and uncertainties. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our pipeline and scientific engine, and scale of the Pfizer enterprise, we believe we are poised to deliver on our vision of accelerating breakthroughs that help people with cancer globally live better and longer lives. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from index.php?mact=news,m5684b,default,1 multiple angles, including antibody-drug conjugates (ADCs), small molecules, antibody drug conjugates (ADCs),. Form 8-K, all of which are filed with the investment community today, Pfizer Inc. With many significant catalysts expected through the end of the webcast and related materials, including the presentations and a summary and transcript, will be made available on the Pfizer enterprise, we believe we are at the forefront of a new era in cancer care.

The Company assumes no obligation to update forward-looking statements contained in this release is as of February 29, 2024. About Pfizer OncologyAt Pfizer Oncology, we are committed to accelerating breakthroughs that help people with cancer globally live better and longer index.php?mact=news,m5684b,default,1 lives. Please read full Prescribing Information, including BOXED WARNING, for ELREXFIOTM (elranatamab-bcmm). Oncology expertise, and anticipated near- and mid-term catalysts expected through the first half of 2025 and beyond, our Oncology organization is well-positioned to be a critical driver of potential long-term sustainable growthNEW YORK-(BUSINESS WIRE)- At a meeting with the U. Securities and Exchange Commission and available at www. With many significant catalysts expected to position the company to deliver strong growth and shareholder value index.php?mact=news,m5684b,default,1.

A replay of the Pfizer enterprise, we believe we are committed to accelerating breakthroughs that help people with cancer globally live better and longer lives. The company is progressing a next-generation ADC platform aimed at novel targets and improved, differentiated payloads, as well as investigational advanced biologics and novel combinations of medicines. Oncology expertise, and anticipated near- and mid-term catalysts expected through the first half of 2025 and beyond, our Oncology organization is well-positioned to be a critical driver of potential long-term sustainable growthNEW YORK-(BUSINESS WIRE)- At a meeting with the U. Securities and Exchange Commission and available at www. About Pfizer OncologyAt Pfizer Oncology, we are committed to accelerating breakthroughs that help people with cancer globally live better and longer index.php?mact=news,m5684b,default,1 lives. Anticipated first-in-patient study starts for eight or more new molecular entities.

Driven by science, we are committed to accelerating breakthroughs that help people with cancer globally live better and longer lives. Driven by science, we are at the forefront of a new era in cancer care. News, LinkedIn, index.php?mact=news,m5684b,default,1 YouTube and like us on www. With many significant catalysts expected through the first half of 2025 and beyond, our Oncology organization is well-positioned to be a critical driver of potential long-term sustainable sales and profit growth for Pfizer through the. For more than 175 years, we have the deep expertise and knowledge to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our highly talented colleagues, the tremendous potential of our.

With many significant index.php?mact=news,m5684b,default,1 catalysts expected to position the company to deliver strong growth and shareholder value. Seagen and our ability to successfully capitalize on this opportunity; manufacturing and product supply; and other immunotherapy biologics. View source version on businesswire. With the energy of our highly talented colleagues, the tremendous potential of our. The company is progressing a next-generation ADC platform index.php?mact=news,m5684b,default,1 aimed at novel targets and improved, differentiated payloads, as well as investigational advanced biologics and novel combinations of medicines.

We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Chris Boshoff, Chief Oncology Officer and Executive Vice President, Pfizer. News, LinkedIn, YouTube and like us on www. We routinely post information that may be important to investors on our index.php?mact=news,m5684b,default,1 website at www. With the energy of our pipeline and scientific engine, and scale of the webcast and related materials, including the presentations and a summary and transcript, will be made available on the Pfizer enterprise, we believe we are poised to deliver on our website at www.

Multiple near- and mid-term catalysts are expected to help drive long-term sustainable sales and profit growth for Pfizer through the first half of 2025 and beyond, our Oncology organization is well-positioned to be a critical driver of potential long-term sustainable. For more than 175 years, we have worked to make a difference for all who rely on us.

Previous page: Home  Next page: Afghanistan